• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用全基因组表达谱分析和跨平台分析鉴定亨廷顿病中的转录变化。

Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.

机构信息

Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V5Z 4H4.

出版信息

Hum Mol Genet. 2010 Apr 15;19(8):1438-52. doi: 10.1093/hmg/ddq018. Epub 2010 Jan 20.

DOI:10.1093/hmg/ddq018
PMID:20089533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2846159/
Abstract

Evaluation of transcriptional changes in the striatum may be an effective approach to understanding the natural history of changes in expression contributing to the pathogenesis of Huntington disease (HD). We have performed genome-wide expression profiling of the YAC128 transgenic mouse model of HD at 12 and 24 months of age using two platforms in parallel: Affymetrix and Illumina. The data from these two powerful platforms were integrated to create a combined rank list, thereby revealing the identity of additional genes that proved to be differentially expressed between YAC128 and control mice. Using this approach, we identified 13 genes to be differentially expressed between YAC128 and controls which were validated by quantitative real-time PCR in independent cohorts of animals. In addition, we analyzed additional time points relevant to disease pathology: 3, 6 and 9 months of age. Here we present data showing the evolution of changes in the expression of selected genes: Wt1, Pcdh20 and Actn2 RNA levels change as early as 3 months of age, whereas Gsg1l, Sfmbt2, Acy3, Polr2a and Ppp1r9a RNA expression levels are affected later, at 12 and 24 months of age. We also analyzed the expression of these 13 genes in human HD and control brain, thereby revealing changes in SLC45A3, PCDH20, ACTN2, DDAH1 and PPP1R9A RNA expression. Further study of these genes may unravel novel pathways contributing to HD pathogenesis. DDBJ/EMBL/GenBank accession no: GSE19677.

摘要

评估纹状体中的转录变化可能是了解导致亨廷顿病(HD)发病机制的表达变化的有效方法。我们使用两种平台平行对 YAC128 转基因 HD 小鼠模型进行了全基因组表达谱分析:Affymetrix 和 Illumina。这两个强大平台的数据被整合到一个综合排名列表中,从而揭示了另外一些被证明在 YAC128 和对照小鼠之间差异表达的基因的身份。使用这种方法,我们鉴定了 13 个在 YAC128 和对照之间差异表达的基因,这些基因在独立的动物队列中通过定量实时 PCR 得到了验证。此外,我们还分析了与疾病病理学相关的其他时间点:3、6 和 9 个月大。在这里,我们展示了数据,显示了选定基因表达变化的演变:Wt1、Pcdh20 和 Actn2 RNA 水平早在 3 个月大时就发生变化,而 Gsg1l、Sfmbt2、Acy3、Polr2a 和 Ppp1r9a RNA 表达水平则在 12 和 24 个月大时受到影响。我们还分析了这些 13 个基因在人类 HD 和对照大脑中的表达,从而揭示了 SLC45A3、PCDH20、ACTN2、DDAH1 和 PPP1R9A RNA 表达的变化。进一步研究这些基因可能揭示导致 HD 发病机制的新途径。DDBJ/EMBL/GenBank 登录号:GSE19677。

相似文献

1
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.使用全基因组表达谱分析和跨平台分析鉴定亨廷顿病中的转录变化。
Hum Mol Genet. 2010 Apr 15;19(8):1438-52. doi: 10.1093/hmg/ddq018. Epub 2010 Jan 20.
2
Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.亨廷顿病YAC128小鼠模型中突变型亨廷顿蛋白的选择性变性与核定位
Hum Mol Genet. 2005 Dec 15;14(24):3823-35. doi: 10.1093/hmg/ddi407. Epub 2005 Nov 8.
3
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease.YAC128 小鼠疾病自然史揭示亨廷顿病病理学的独特特征。
Neurobiol Dis. 2011 Jul;43(1):257-65. doi: 10.1016/j.nbd.2011.03.018. Epub 2011 Mar 31.
4
Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC128小鼠模型中,反义寡核苷酸介导的转录失调校正与行为改善相关。
J Huntingtons Dis. 2013;2(2):217-28. doi: 10.3233/JHD-130057.
5
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.亨廷顿病YAC128小鼠模型中的选择性纹状体神经元丢失。
Hum Mol Genet. 2003 Jul 1;12(13):1555-67. doi: 10.1093/hmg/ddg169.
6
Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.聚谷氨酰胺调节的YAC转基因亨廷顿病小鼠模型纹状体钙蛋白酶活性:对NMDA受体功能和毒性的影响
J Neurosci. 2008 Nov 26;28(48):12725-35. doi: 10.1523/JNEUROSCI.4619-08.2008.
7
Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease.环境富集可减少亨廷顿病小鼠模型神经元核内包涵体负荷,但对信使 RNA 表达无影响。
J Neuropathol Exp Neurol. 2010 Aug;69(8):817-27. doi: 10.1097/NEN.0b013e3181ea167f.
8
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC小鼠模型中,全长突变型亨廷顿蛋白对于纹状体神经元Ca2+信号改变和细胞凋亡是必需的。
Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.
9
Transcriptional abnormalities in Huntington disease.亨廷顿舞蹈症中的转录异常。
Trends Genet. 2003 May;19(5):233-8. doi: 10.1016/S0168-9525(03)00074-X.
10
P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.P38MAPK 参与亨廷顿病 YAC 转基因小鼠模型中增强的 NMDA 受体依赖性兴奋性毒性。
Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019. Epub 2011 Dec 14.

引用本文的文献

1
SSL-VQ: vector-quantized variational autoencoders for semi-supervised prediction of therapeutic targets across diverse diseases.SSL-VQ:用于跨多种疾病进行治疗靶点半监督预测的矢量量化变分自编码器。
Bioinformatics. 2025 Feb 4;41(2). doi: 10.1093/bioinformatics/btaf039.
2
DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson's disease.DDHA-1 维持内质网-线粒体接触,保护帕金森病中的多巴胺能神经元。
Cell Death Dis. 2024 Jun 7;15(6):399. doi: 10.1038/s41419-024-06772-w.
3
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.亨廷顿病 Q175 小鼠的 TYROBP/DAP12 基因敲除细胞自主降低小胶质细胞中与疾病相关基因的表达,而非细胞自主减轻星形胶质细胞增生和运动功能恶化。
J Neuroinflammation. 2024 Mar 8;21(1):66. doi: 10.1186/s12974-024-03052-4.
4
Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.揭开表观遗传交响乐的面纱:组蛋白乙酰化对神经退行性疾病中神经行为改变的影响。
Epigenomics. 2024 Mar;16(5):331-358. doi: 10.2217/epi-2023-0428. Epub 2024 Feb 7.
5
Environmental Deprivation Effects on Myelin Ultrastructure in Huntington Disease and Wildtype Mice.环境剥夺对亨廷顿病和野生型小鼠髓鞘超微结构的影响。
Mol Neurobiol. 2024 Jul;61(7):4278-4288. doi: 10.1007/s12035-023-03799-6. Epub 2023 Dec 11.
6
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development.一种新型亨廷顿舞蹈症评估平台,旨在支持未来的药物发现和开发。
Int J Mol Sci. 2022 Nov 25;23(23):14763. doi: 10.3390/ijms232314763.
7
Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.证据表明,突变亨廷顿蛋白通过干扰雄性亨廷顿病动物的睾丸酮生物合成,导致骨骼肌肉和大脑生长受损。
Cells. 2022 Nov 25;11(23):3779. doi: 10.3390/cells11233779.
8
Postnatal Conditional Deletion of in Striatal Projection Neurons Mimics the Transcriptional Signature of Huntington's Disease.纹状体投射神经元中 的产后条件性缺失模拟了亨廷顿舞蹈病的转录特征。 (注:原文中“of”后面似乎缺失了关键内容)
Biomedicines. 2022 Sep 23;10(10):2377. doi: 10.3390/biomedicines10102377.
9
mRNA isoform balance in neuronal development and disease.mRNA 异构体平衡在神经元发育和疾病中的作用。
Wiley Interdiscip Rev RNA. 2023 May-Jun;14(3):e1762. doi: 10.1002/wrna.1762. Epub 2022 Sep 19.
10
Comprehensive analysis of lncRNA-mRNAs co-expression network identifies potential lncRNA biomarkers in cutaneous squamous cell carcinoma.综合分析 lncRNA-mRNAs 共表达网络鉴定皮肤鳞状细胞癌潜在的 lncRNA 生物标志物。
BMC Genomics. 2022 Apr 7;23(1):274. doi: 10.1186/s12864-022-08481-0.

本文引用的文献

1
Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAs.通过共纯化的 mRNA 鉴定肾小球足细胞中肌动蛋白相关细胞骨架蛋白的假定网络。
PLoS One. 2009 Aug 4;4(8):e6491. doi: 10.1371/journal.pone.0006491.
2
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.SLC45A3-ELK4是一种在前列腺癌中发现的新型且常见的成红细胞转化特异性融合转录本。
Cancer Res. 2009 Apr 1;69(7):2734-8. doi: 10.1158/0008-5472.CAN-08-4926. Epub 2009 Mar 17.
3
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.FUS(一种RNA加工蛋白)中的突变会导致6型家族性肌萎缩侧索硬化症。
Science. 2009 Feb 27;323(5918):1208-1211. doi: 10.1126/science.1165942.
4
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.16号染色体上FUS/TLS基因的突变会导致家族性肌萎缩侧索硬化症。
Science. 2009 Feb 27;323(5918):1205-8. doi: 10.1126/science.1166066.
5
Canonical WNT signalling determines lineage specificity in Wilms tumour.经典WNT信号通路决定肾母细胞瘤的谱系特异性。
Oncogene. 2009 Feb 26;28(8):1063-75. doi: 10.1038/onc.2008.455. Epub 2009 Jan 12.
6
Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.亨廷顿蛋白调节转录,在体内占据基因启动子,并以多聚谷氨酰胺依赖的方式直接与DNA结合。
J Neurosci. 2008 Oct 15;28(42):10720-33. doi: 10.1523/JNEUROSCI.2126-08.2008.
7
Mechanisms of neurodegeneration in Huntington's disease.亨廷顿舞蹈症中的神经退行性变机制。
Eur J Neurosci. 2008 Jun;27(11):2803-20. doi: 10.1111/j.1460-9568.2008.06310.x.
8
Huntington's disease: from pathology and genetics to potential therapies.亨廷顿舞蹈病:从病理学、遗传学至潜在疗法
Biochem J. 2008 Jun 1;412(2):191-209. doi: 10.1042/BJ20071619.
9
Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC128小鼠模型中通过磁共振成像测量皮质厚度。
Neuroimage. 2008 Jun;41(2):243-51. doi: 10.1016/j.neuroimage.2008.02.019. Epub 2008 Feb 26.
10
Postmortem delay has minimal effect on brain RNA integrity.死后延迟对脑RNA完整性的影响极小。
J Neuropathol Exp Neurol. 2007 Dec;66(12):1093-9. doi: 10.1097/nen.0b013e31815c196a.